These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 2767511

  • 1. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
    Konturek JW, Konturek SJ, Kurek A, Bogdal J, Oleksy J, Rovati L.
    Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
    [Abstract] [Full Text] [Related]

  • 2. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE, Creutzfeldt W, Höcker M, Choudhury AR, Nustede R, Schleser A, Nitsche R, Rovati LC, Schafmayer A, Fölsch UR.
    Digestion; 1990 Aug; 46 Suppl 2():232-9. PubMed ID: 2262057
    [Abstract] [Full Text] [Related]

  • 3. Comparison of loxiglumide, a cholecystokinin receptor antagonist, and atropine on hormonal and meal-stimulated pancreatic secretion in man.
    Gabryelewicz A, Kulesza E, Konturek SJ.
    Scand J Gastroenterol; 1990 Jul; 25(7):731-8. PubMed ID: 2396088
    [Abstract] [Full Text] [Related]

  • 4. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE, Creutzfeldt W, Schleser A, Choudhury AR, Nustede R, Höcker M, Nitsche R, Sostmann H, Rovati LC, Fölsch UR.
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [Abstract] [Full Text] [Related]

  • 5. Dose-response effects of oral loxiglumide on postprandial gall-bladder emptying in man.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Bekkering M, Giacovelli G, D'Amato M, Rovati LC.
    Arzneimittelforschung; 1992 Nov; 42(11):1359-62. PubMed ID: 1492852
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
    Konturek JW.
    J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
    [Abstract] [Full Text] [Related]

  • 7. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E, Ricci R, Biliotti D, Bontempo I, De Medici A, Pallotta N, Torsoli A.
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [Abstract] [Full Text] [Related]

  • 8. Effect of loxiglumide on gallbladder contractile response to cerulein and food in humans.
    Malesci A, De Fazio C, Festorazzi S, Bonato C, Valentini A, Tacconi M, Rovati L, Setnikar I.
    Gastroenterology; 1990 May; 98(5 Pt 1):1307-10. PubMed ID: 2323521
    [Abstract] [Full Text] [Related]

  • 9. Effects of CCK receptor blockade on intestinal motor activity in conscious dogs.
    Niederau C, Karaus M.
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G315-24. PubMed ID: 1996649
    [Abstract] [Full Text] [Related]

  • 10. Effects of somatostatin and loxiglumide on gallbladder motility.
    Lieverse RJ, Jansen JB, Jebbink MC, Masclee AA, Rovati LC, Lamers CB.
    Eur J Clin Pharmacol; 1995 Feb; 47(6):489-92. PubMed ID: 7768249
    [Abstract] [Full Text] [Related]

  • 11. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
    Hildebrand P, Ensinck JW, Ketterer S, Delco F, Mossi S, Bangerter U, Beglinger C.
    J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
    [Abstract] [Full Text] [Related]

  • 12. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
    Jebbink MC, Jansen JB, Masclee AA, Lamers CB.
    Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
    [Abstract] [Full Text] [Related]

  • 13. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
    [Abstract] [Full Text] [Related]

  • 14. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M, Fujii M, Nakamura T, Okabayashi Y, Tani S, Fujisawa T, Koide M, Baba S.
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [Abstract] [Full Text] [Related]

  • 15. Effects of cholecystokinin-receptor blockade on pancreatic and biliary function in healthy volunteers.
    Schwarzendrube J, Niederau M, Lüthen R, Niederau C.
    Gastroenterology; 1991 Jun; 100(6):1683-90. PubMed ID: 2019374
    [Abstract] [Full Text] [Related]

  • 16. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
    Baum F, Nauck MA, Ebert R, Cantor P, Hoffmann G, Choudhury AR, Schmidt WE, Creutzfeldt W.
    Digestion; 1992 Jun; 53(3-4):189-99. PubMed ID: 1291406
    [Abstract] [Full Text] [Related]

  • 17. Anticholecystokinin activities of loxiglumide.
    Setnikar I, Bani M, Cereda R, Chisté R, Makovec F, Pacini MA, Revel L.
    Arzneimittelforschung; 1987 Oct; 37(10):1168-71. PubMed ID: 3435589
    [Abstract] [Full Text] [Related]

  • 18. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P, Beglinger C, Gyr K, Jansen JB, Rovati LC, Zuercher M, Lamers CB, Setnikar I, Stalder GA.
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F, Bani M, Cereda R, Chisté R, Pacini MA, Revel L, Rovati LA, Rovati LC, Setnikar I.
    Arzneimittelforschung; 1987 Nov; 37(11):1265-8. PubMed ID: 3440035
    [Abstract] [Full Text] [Related]

  • 20. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
    Niederau C, Heintges T, Rovati L, Strohmeyer G.
    Gastroenterology; 1989 Nov; 97(5):1331-6. PubMed ID: 2792664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.